Refractory Pancreatic Carcinoma
specificPancreatic carcinoma that does not respond to treatment.
10
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Refractory Pancreatic Carcinoma(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | UF Health Cancer InstituteGainesville, FL NCI Clinical High-Volume Research Center | 75.2 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 52.8 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 52.8 |
| 4 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 52.8 |
| 5 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 52.8 |
| 6 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 52.8 |
| 7 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 52.8 |
| 8 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 52.8 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 52.8 |
| 10 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 52.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →